| Icosagen | |
| Type: | Privately held company |
| Foundation: | 1999 |
| Location: | Tartu, Estonia |
| Key People: | Mart Ustav, CEO |
| Industry: | Biotechnology, Biopharmaceutical industry |
| Products: | Products and services in functional genomics and proteomics, latex allergen tests |
| Services: | Certification |
Icosagen AS is one of the leading biotechnology companies in Estonia[1] providing medical diagnostics services and performing custom research programs for the biopharmaceutical industry. Formed in 1999 as Quattromed AS, the company has been called Icosagen since 2009.[2]
Quattromed was established in 1999 as a spin-off from Tartu University.[3] It is based in Tartu, Estonia. Employing 80 full-time employees, it has grown into the largest biotechnology company in Estonia. Quattromed started with offering molecular diagnostic services, the activities today cover molecular and clinical diagnostics (Quattromed HTI Laboratories), life science products (Quattromed), latex allergen testing (Quattromed Ltd) and protein production (Quattromed Cell Factory).
Quattromed’s activities are divided into three branches: medical diagnostics division, technology development division and life science products division. Its main focus of activities is in gene expression and protein production. In-house proprietary technologies are used combined with extensive process know-how and partnership with academic and industrial groups. Quattromed has three patent applications in its IP portfolio, about ten technology licenses and one trade mark.